Warning: The NCBI web site requires JavaScript to function. more...
Harm reduction and equity of access to care for French prisoners: a review.
Michel L, Carrieri MP, Wodak A.
Harm Reduct J. 2008 May 21;5:17.
Related citations
Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.
Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah I, Adu-Gyamfi C, Asare I, Hesse IF, Mensah G.
BMC Infect Dis. 2008 Mar 7;8:33.
Social characteristics, HIV/AIDS knowledge, preventive practices and risk factors elicitation among prisoners in Lagos, Nigeria.
Odujinrin MT, Adebajo SB.
West Afr J Med. 2001 Jul-Sep;20(3):191-8.
Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy.
Michel L, Jauffret-Roustide M, Blanche J, Maguet O, Calderon C, Cohen J, Carrieri PM; ANRS PRI²DE study group.
BMC Public Health. 2011 May 27;11:400.
Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
Skipper C, Guy JM, Parkes J, Roderick P, Rosenberg WM.
Gut. 2003 Oct;52(10):1500-4.
Prisoners who inject drugs: public health and human rights imperatives.
Jürgens R, Betteridge G.
Health Hum Rights. 2005;8(2):46-74. Review.
Harm reduction and women in the Canadian national prison system: policy or practice?
Rehman L, Gahagan J, DiCenso AM, Dias G.
Women Health. 2004;40(4):57-73.
[Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
[No authors listed]
Rev Esp Salud Publica. 1998 Jan-Feb;72(1):43-51. Spanish.
HIV in prison: what are the risks and what can be done?
Hellard ME, Aitken CK.
Sex Health. 2004;1(2):107-13. Review.
[The place of syringe exchange programs in reducing harm in Canadian prisoners].
Orsi MM, Brochu S.
Can J Public Health. 2009 Jan-Feb;100(1):29-31. French.
Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J, Desenclos JC.
Addiction. 2005 Nov;100(11):1690-700. Erratum in: Addiction. 2006 Apr;101(4):616.
Prevalence of HIV infection in provincial prisons in British Columbia.
Rothon DA, Mathias RG, Schechter MT.
CMAJ. 1994 Sep 15;151(6):781-7.
[Guidelines for substitution treatments in prison populations].
Michel L, Maguet O.
Encephale. 2005 Jan-Feb;31(1 Pt 1):92-7. French.
How to anticipate the assessment of the public health benefit of new medicines?
Massol J, Puech A, Boissel JP; Participants inRound Table No 7, Giens XXII.
Therapie. 2007 Sep-Oct;62(5):427-35. Epub 2008 Jan 19.
Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study.
Rotily M, Weilandt C, Bird SM, Käll K, Van Haastrecht HJ, Iandolo E, Rousseau S.
Eur J Public Health. 2001 Sep;11(3):243-50.
A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
Larney S, Dolan K.
Eur Addict Res. 2009;15(2):107-12. Epub 2009 Feb 2. Review.
A lasting public health response to an outbreak of HIV infection in a Scottish prison?
Goldberg D, Taylor A, McGregor J, Davis B, Wrench J, Gruer L.
Int J STD AIDS. 1998 Jan;9(1):25-30.
Successful linkage of medical care and community services for HIV-positive offenders being released from prison.
Rich JD, Holmes L, Salas C, Macalino G, Davis D, Ryczek J, Flanigan T.
J Urban Health. 2001 Jun;78(2):279-89.
The transfer of harm-reduction strategies into prisons: needle exchange programmes in two German prisons.
Jacob J, Stöver H.
Int J Drug Policy. 2000 Sep 1;11(5):325-335.
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on